PURA VIDA INVESTMENTS, LLC - 06 Mar 2023 Form 4/A - Amendment Insider Report for Oncocyte Corp (OCX)

Role: 10%+ Owner
Signature: /s/ Efrem Kamen, Managing Member of Pura Vida Investments, LLC
Issuer symbol: OCX
Transactions as of: 06 Mar 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 18 Apr 2023, 18:49:49 UTC
Date Of Original Report: 08 Mar 2023
Previous filing: 28 Jun 2022
Next filing: 07 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCX	Common Stock	Other		-3,890,111	-46%		4,589,571	06 Mar 2023	By the Managed Accounts.	F1, F2, F3, F4
holding	OCX	Common Stock						767,952	06 Mar 2023	By Pura Vida X Fund LP	F3, F4
holding	OCX	Common Stock						1,381,438	06 Mar 2023	By the Retirement Trust	F3, F4
holding	OCX	Common Stock						7,427,202	06 Mar 2023	By Pura Vida Master Fund, Ltd.	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCX	Warrant to purchase common stock	Other		-440,964	-46%		517,245	06 Mar 2023	Common Stock	440,964	$1.53	By the Managed Accounts.	F2, F5, F6
holding	OCX	Warrant to purchase common stock						832,949	06 Mar 2023	Common Stock	832,949	$1.53	By Pura Vida Master Fund, Ltd.	F6
holding	OCX	Warrant to purchase common stock						383,976	06 Mar 2023	Common Stock	383,976	$1.53	By Pura Vida X Fund LP	F6
holding	OCX	Warrant to purchase common stock						690,719	06 Mar 2023	Common Stock	690,719	$1.53	By the Retirement Trust	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	As of March 6, 2023, the Reporting Persons no longer have voting and dispositive power for certain Managed Accounts and therefore such shares are no longer deemed beneficially owned by the Reporting Persons.
F2	Not applicable.
F3	Securities reported herein are owned by Pura Vida Master Fund, Ltd., Pura Vida X Fund LP, and Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust") and certain separately managed accounts (the "Managed Accounts" and collectively, the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.
F4	By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.
F5	As of March 6, 2023, the Reporting Persons no longer have voting and dispositive power for certain Managed Accounts and therefore the warrants and the underlying common stock are no longer deemed beneficially owned by the Reporting Persons.
F6	See footnotes 3 and 4.

Remarks:

This amendment is being filed to include information about warrants, which was inadvertently omitted from the original Form 4.